Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients

NCT01572818 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2016-06-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate efficacy of phlebotomy on insulin sensitivity as evaluated by euglycemic-hyperinsulinic clamp in insulin resistance-associated hepatic iron overload patients.

Conditions

Interventions

PROCEDURE

phlebotomy

7 ml/kg without exceeding 500 mL

BEHAVIORAL

dietary and lifestyle counseling

dietary and lifestyle counseling

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Fabrice BONNET, MD, PHD · Rennes University Hospital

  • Eric Bellissant, MD, PhD · RennesUniversity Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01572818 on ClinicalTrials.gov